The different clinical effects of anti-BLyS, anti-APRIL and anti-CD20 antibodies point at a critical pathogenic role of γ-herpesvirus infected B cells in the marmoset EAE model.
about
Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?Induction of encephalitis in rhesus monkeys infused with lymphocryptovirus-infected B-cells presenting MOG(34-56) peptide.Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvantThe Role of Latently Infected B Cells in CNS Autoimmunity.Lymphocryptovirus Infection of Nonhuman Primate B Cells Converts Destructive into Productive Processing of the Pathogenic CD8 T Cell Epitope in Myelin Oligodendrocyte GlycoproteinAnalysis of the cross-talk of Epstein-Barr virus-infected B cells with T cells in the marmoset.The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis.The primate autoimmune encephalomyelitis model; a bridge between mouse and man.Illuminating vitamin D effects on B cells--the multiple sclerosis perspective.An essential role of virus-infected B cells in the marmoset experimental autoimmune encephalomyelitis model.Common marmoset (Callithrix jacchus) as a primate model for behavioral neuroscience studies.Myelin oligodendrocyte glycoprotein has a dual role in T cell autoimmunity against central nervous system myelin.EBV Infection Empowers Human B Cells for Autoimmunity: Role of Autophagy and Relevance to Multiple Sclerosis.Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis.
P2860
Q27015811-A4EBA682-7ECA-4B23-B60C-6D300BFD0BECQ34971488-239D67EE-C028-405A-8B0C-2C56A985EC38Q36071018-AB0B94AD-1320-4711-87FA-39F89840A23BQ36216025-FB9BE21F-1484-4983-9F71-7C7686F7A8CFQ37153675-702835E3-2567-444C-8506-4E95AC9CDA57Q37644275-EE5BA3EA-2ACE-4900-97DF-2DEB1EF6585BQ38115525-258984E3-34AB-40BE-9B2B-FDFC38AA7538Q38497590-CD742FF9-C9BE-49AF-949E-090D2A39DA88Q38682352-556C7795-A0EB-4581-85B8-DB36A59B57D6Q38728578-7B131B9E-75AC-418F-BB16-609D62C5A865Q38841759-A8EFCA32-272D-46B6-A270-C33E9A41E051Q39368254-05EEC842-0A03-4129-BDCC-F1F62A82349EQ40181000-53A6E5E5-AF41-43D6-AFA3-8E232530F853Q46686185-73FFCF9A-15F8-4F37-A2B6-812D8E39AD52
P2860
The different clinical effects of anti-BLyS, anti-APRIL and anti-CD20 antibodies point at a critical pathogenic role of γ-herpesvirus infected B cells in the marmoset EAE model.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The different clinical effects ...... lls in the marmoset EAE model.
@en
The different clinical effects ...... lls in the marmoset EAE model.
@nl
type
label
The different clinical effects ...... lls in the marmoset EAE model.
@en
The different clinical effects ...... lls in the marmoset EAE model.
@nl
prefLabel
The different clinical effects ...... lls in the marmoset EAE model.
@en
The different clinical effects ...... lls in the marmoset EAE model.
@nl
P2093
P2860
P1476
The different clinical effects ...... ells in the marmoset EAE model
@en
P2093
Bert A 't Hart
Ernst J Verschoor
Jon D Laman
Nicole Heijmans
S Anwar Jagessar
Thi Migone
Zahra Fagrouch
P2860
P2888
P304
P356
10.1007/S11481-013-9448-6
P50
P577
2013-03-19T00:00:00Z